3 research outputs found

    Numerical simulation of particulateflow in spiral separators (15 % solids)

    Get PDF
    Spiral separator is a gravity concentration device. It wasinvented by Humphreys in 1941.It is firstly designed anddeveloped based on experience and through many testingof prototypes and modifications. The main objective of thepresent study is simulation of the particulate-flow of morerealistic solids concentration (15% solids by weight) in spiralseparator. The study is based on Eulerian approach and RING K-E turbulence modelin. The results focus on particulate-flow characteristics such as velocity, and distribution and concentration of particulates on the spiral trough.The predicted results are compared with the experimentalin case LD9 coal spiral. Comparisons between numericaland measured data show good agreement

    Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry

    No full text
    Aims: Hypertensive disorders occur in women with peripartum cardiomyopathy (PPCM). How often hypertensive disorders co-exist, and to what extent they impact outcomes, is less clear. We describe differences in phenotype and outcomes in women with PPCM with and without hypertensive disorders during pregnancy. Methods: The European Society of Cardiology PPCM Registry enrolled women with PPCM from 2012-2018. Three groups were examined: 1) women without hypertension (‘PPCM-noHTN’); 2) women with hypertension but without pre-eclampsia (‘PPCM-HTN’); 3) women with pre-eclampsia (‘PPCM-PE’). Maternal (6-month) and neonatal outcomes were compared. Results: Of 735 women included, 452 (61.5%) had PPCM-noHTN, 99 (13.5%) had PPCM-HTN and 184 (25.0%) had PPCM-PE. Compared to women with PPCM-noHTN, women with PPCM-PE had more severe symptoms (NYHA IV in 44.4% and 29.9%, p<0.001), more frequent signs of heart failure (pulmonary rales in 70.7% and 55.4%, p=0.002), higher baseline LVEF (32.7% and 30.7%, p=0.005) and smaller left ventricular end diastolic diameter (57.4mm [±6.7] and 59.8mm [±8.1], p<0.001). There were no differences in the frequencies of death from any cause, re-hospitalization for any cause, stroke, or thromboembolic events. Compared to women with PPCM-noHTN, women with PPCM-PE had a greater likelihood of left ventricular recovery (LVEF≄50%) (adjusted OR 2.08 95% CI 1.21-3.57) and an adverse neonatal outcome (composite of termination, miscarriage, low birth weight or neonatal death) (adjusted OR 2.84 95% CI 1.66-4.87). Conclusion: Differences exist in phenotype, recovery of cardiac function and neonatal outcomes according to hypertensive status in women with PPCM
    corecore